Metabolism

Items 11-20 of 23

Page
per page
Set Descending Direction
  1. anti-FTO, mAb (FT86-4)
    AG-20A-0064
    AG-20A-0064-C05050 µg
    CHF 270.00
    AG-20A-0064-C100100 µg
    CHF 350.00
    Immunoprecipitation of recombinant human FTO using anti-FTO (human), mAb (FT86-4) (Prod. No. AG-20A-0064). Recombinant human FTO proteins at different concentrations were precipitated by FT86-4. The precipitated proteins were separated by SDS-PAGE, electr
  2. anti-GLUT1, pAb (IN116)
    AG-25B-0040
    AG-25B-0040-C05050 µg
    CHF 240.00
    anti-GLUT1, pAb (IN116)
  3. anti-GLUT2 (human), pAb (IN117)
    AG-25B-0041
    AG-25B-0041-C05050 µg
    CHF 240.00
    anti-GLUT2 (human), pAb (IN117)
  4. anti-GLUT2 (mouse), pAb (IN118)
    AG-25B-0042
    AG-25B-0042-C05050 µg
    CHF 240.00
    anti-GLUT2 (mouse), pAb (IN118)
  5. anti-GLUT2 (rat), pAb (IN119)
    AG-25B-0043
    AG-25B-0043-C05050 µg
    CHF 240.00
    anti-GLUT2 (rat), pAb (IN119)
  6. anti-Hairy and Enhancer of Split 1 (HES1), mAb (7H11)
    AG-20T-0400
    AG-20T-0400-C100100 µg
    CHF 380.00
    Western blot analysis using anti-HES1, mAb (7H11) (Prod. No. AG-20T-0400) in cell lysates. Lane1: HeLa cell lysate; Lane 2: HT29 cell lysate; Lane 3: BeWo cell lysate.
  7. anti-MPC-2, mAb (JCM-1)
    AG-20B-0071
    AG-20B-0071-C100100 µg
    CHF 540.00
  8. anti-Nampt (Visfatin/PBEF), mAb (OMNI379)
    AG-20A-0034
    AG-20A-0034-C05050 µg
    CHF 290.00
    AG-20A-0034-C100100 µg
    CHF 410.00
    Immunoprecipitation of recombinant human Nampt(Visfatin/PBEF) proteins using anti-Nampt (Visfatin-PBEF), mAb (OMNI379) (Prod. No. AG-20A-0034). Recombinant human Nampt(Visfatin/PBEF) proteins at different concentrations were precipitated. The precipitated
  9. anti-NF-κB (p65), pAb
    AG-25T-0004
    AG-25T-0004-R100100 µl
    CHF 290.00
  10. anti-PARP-1 [ARTD1] (human), pAb
    AG-25T-0002
    AG-25T-0002-R100100 µl
    CHF 280.00

Items 11-20 of 23

Page
per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.